In this podcast, Dr Gregory Goldmacher, Executive Director, Translational Biomarkers and Head of Clinical Imaging, Merck Research Labs along with Dr Matthew Silva, Executive Vice President, Scientific Applications, Invicro discuss innovations in IO imaging.

Together, Dr Goldmacher and Dr Silva address:

The evolution of treatment response criteria in immuno-oncology
Novel Tracers: Monitoring tumor or immune cell populations with imaging
Radiomics, AI and Digital Biomarkers

Join us February 26-28, 2020 in NYC for the 6th annual Immuno-Oncology 360° Summit where we will continue to expand on imaging aspects for cancer immunotherapy. To learn more visit www.theconferenceforum.org

Innovations in Immuno-Oncology Imaging

Share

Embed